|
rP-nano™ TECHNOLOGY
Working closely with Novozymes Biopharma UK Ltd., recent development breakthroughs have resulted in a next generation technology for producing nano-sized particles from proteins with unique competitive advantages.
With Nanobiomolecules' technology, nano-sized particles can be produced from all peptides, proteins (including monoclonal antibodies and enzymes) and other molecules with suitable reactive side chains.
Key attributes:
- Size can be precisely controlled from 10nm to 120nm
- Size allows sterile filtration through 0.2µm filter
- Proteins in particles are not denaturated
- Particles are very stable and amenable to freeze-drying
Simplicity of manufacturing:
Nanobiomolecules' production process is very robust, simple and reproducible.
Loading of nanoparticles:
Nanobiomolecules' particles can be efficiently and densely loaded with drugs or other substances.
Services:
Nanobiomolecules' extensive know-how in producing nanoparticles from biomolecules and in loading particles with drugs and other substances can substantially reduce development time and cost for its licensing partners.
 |
For more information about rP-nano™ and its applications,
click
here to download our factsheet, or contact us. |
|
